Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study

Journal of Hypertension

Volumn 18, Issue 5, 2000, Pages 629-642

  Kjeldsen, Sverre E ^a   Kolloch, Rainer E ^b   Leonetti, Gastone ^c   Mallion, Jean Michel ^d   Zanchetti, Alberto ^e   Elmfeldt, Dag ^f   Warnold, Ingrid ^f   Hansson, Lennart ^g  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITY OF MILAN   (Italy)

^f ASTRAZENECA R AND D   (Sweden)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acetylsalicylic acid; Anti hypertensive treatment; Blood pressure; Cardiovascular disease; Myocardial infarction; Randomized trial; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; FELODIPINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DYSPEPSIA; EDEMA; FATIGUE; FEMALE; FLUSHING; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STROKE; VERTIGO;

EID: 0034107309     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018050-00017     Document Type: Article

References (20)

1. 1 The HOT Study Group. The Hypertension Optimal Treatment Study (the HOT Study). Blood Pressure 1993; 2:62-68.
2. 2 Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.
3. 3 Hansson L, Zanchetti A for the HOT Study Group. The Hypertension Optimal Treatment (HOT) study - patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Pressure 1994:3:322-327.
4. 4 Hansson L, Zanchetti A for the HOT Study Group. The Hypertension Optimal Treatment (HOT) study: 12-month data on blood pressure and tolerability. With special reference to age and gender. Blood Pressure 1995:4:313-319.
5. 5 Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded End-point (PROBE) study: a novel design for intervention trials. Blood Pressure 1992; 1:113-119.
6. 6 O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O'Malley K. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11 (suppl 2):S43-S62.
7. 7 Lithell H, Berglund, L. Validation of an oscillometric blood pressure measuring device: a substudy of the HOT Study. Blood Pressure 1998;7:149-152.
8. 8 Kjeldsen SE, Hedner T, Jamerson K, Julius S, Haley WE, Zabalgoitia M, et al. for the HOT Study Group. Hypertension Optimal Treatment (HOT) Study. Home blood pressure in treated hypertensive subjects. Hypertension 1998; 31:1014-1020.
9. 9 Dahlöf B, Lindholm L, Hansson L, Scherstên B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 1991; 338:1281-1285.
10. 10 Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979; i:861-865.
11. 11 Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; i:581-584.
12. 12 Alderman MH, Ooi WL, Madhavan S, Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989; 262:920-924.
13. 13 Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension: results from the Primary Prevention Trial in Göteborg, Sweden. JAMA 1987; 258:1768-1776.
14. 14 Wiklund I, Halling K, Rydén-Bergsten T, Fletcher A on behalf of the HOT Study Group. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) Study. Blood Pressure 1997; 6:357-364.
15. 15 Antiplatelet Trialists' Collaboration. Collabrative overview of randomized trials of antiplatelet therapy. 1: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106.
16. 16 Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ 1988; 296:313-316.
17. 17 Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321:129-135.
18. 18 Kjeldsen SE, Neubig RR, Weder AB, Zweifler AJ. The hypertension-coronary heart disease dilemma: the catecholamine-blood platelet connection. J Hypertens 1989; 7:851-869.
19. 19 Mundal HH, Nordby G, Lande K, Gjesdal K, Kjeldsen SE, Os I. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women. Scand J Clin Lab Invest 1993; 53:585-591.
20. 20 Waeber B, Leonetti G, Kolloch R, McInnes GT for the HOT Study Group. Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens 1999; 17:1041-1045.